Variable

Suppressed VL

n (%)

High VL

n (%)

RR

CI

p-value

Mean age

15.32 ± 2.621

13.90 ± 2.367

3.301

0.567 - 2.263

0.001**

Gender

Male

33 (44.0)

30 (47.6)

0.935

0.687 - 1.274

0.800

Female

42 (56.0)

33 (52.4)

Number of EAC Sessions

3.16 ± 0.546

3.05 ± 0.792

0.982

0.114 - 0.339

0.028*

Duration in support group

7.88 ± 3.650

5.18 ± 2.113

2.698

1.347 - 4.050

0.001**

First viral load*

7994 (2737 - 25,268)

19,731 (10,142 - 57,641)

3.540

0.001**

Opportunistic infections

Yes

21 (28.0)

9 (14.3)

1.400

1.036 - 1.891

0.082

No

54 (72.0)

54 (85.7)

ART regimen

1st line

66 (88.0)

57 (90.5)

0.894

0.573 - 1.395

0.642

2^nd line

9 (12.0)

6 (9.5)

WHO staging at initiation

Stage 1

36 (48.0)

33 (52.4)

0.923

0.679 - 1.254

0.733

Stage 2

21 (28.0)

24 (38.1)

0.804

0.562 - 1.148

0.281

Stage 3

12 (16.0)

6 (33.3)

1.270

0.879 - 1.835

0.383

Stage 4

6 (8.0)

0 (0.0)

/

/

0.031*